Consumers buying hand sanitizer are shopping the set multiple times because of different needs, noted Tim Cleary, VP sales at Purell Consumer, suggesting there may be a latent opportunity for the already-growing Purell Advanced formula, which generated $20.6 million in sales, up 25.2%, for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.
Alexa Health Products’ FruitChia bars have garnered a great deal of attention over the past year. Made with only two ingredients — fruit and chia seeds — the naturally sweetened, gluten-free bars provide a mixture of antioxidants, dietary fiber, and omega-3 and omega-6 essential fatty acids.
Researchers at the University of California, San Diego School of Medicine concluded that aspirin, in addition to preventing pain and inflammation, actually helps hasten the end of inflammation in a study published this week in the online early edition of PNAS.
The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.
Nearly half of women age 45 years or older who experience symptoms of overactive bladder report their current treatment does not address their OAB symptoms, according to a recent survey conducted by The Harris Poll on behalf of Allergan.
Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs, according to data published last week in Cancer Research, a journal of the American Association for Cancer Research.
High-dose influenza vaccine is 24% more effective than the standard-dose vaccine in protecting persons ages 65 and older against influenza illness and its complications, according to a Vanderbilt-led study published Wednesday in the New England Journal of Medicine.
Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million.
Michael Taylor, who currently serves as the Food and Drug Administration's deputy commissioner for foods and veterinary medicine, outlined the importance for companies to adhere to gluten-free guidelines in a post on FDA Voice.
New York City's Department of Health and Mental Hygiene said a man who was tested for Ebola at Mount Sinai Hospital is "unlikely" to have the virus. The patient was admitted to the hospital early Monday with a fever and gastrointestinal problems. He recently visited a West African country where Ebola was reported, according to the Washington Post.
A new study published in the July issue of the Journal of Bone and Mineral Research found no increased risk of coronary heart disease or all-cause mortality in post-menopausal women supplementing with calcium and vitamin D.
Sam's Club on Wednesday announced that it is offering DNA testing and fingerprint kits as a part of their annual free children's health screenings, both standard tools for personal identification that can be useful for parents should they ever be needed, on Saturday, Aug. 9.